|Day's Range||19.05 - 19.70|
|52 Week Range||11.81 - 20.30|
|PE Ratio (TTM)||62.18|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Solid expansion across athenahealth's (ATHN) ambulatory, hospital and population health platforms is expected to provide a competitive edge in the niche RCM space.
Intuitive Surgical posted solid numbers in the quarter under review, courtesy of rising customer adoption of procedures and growth in system placements.
AngioDynamics (ANGO) revenues declined year over year in the fourth quarter. Recall of the Acculis product line under the oncology segment is also a concern.